The Moving Average Convergence Divergence (MACD) for FMED turned positive on November 09, 2026. Looking at past instances where FMED's MACD turned positive, the stock continued to rise in 29 of 33 cases over the following month. The odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on November 19, 2026. You may want to consider a long position or call options on FMED as a result. In 49 of 59 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
FMED moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for FMED crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.
Following a +4.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMED advanced for three days, in 171 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 124 of 143 cases where FMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
FMED broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
VRTX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 60 instances where the indicator turned negative. In 31 of the 60 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 52%.
The 10-day RSI Indicator for VRTX moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 21 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 49%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VRTX as a result. In 38 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 43%.
VRTX moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for VRTX crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.
Following a +1.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where VRTX advanced for three days, in 235 of 368 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
VRTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 182 of 285 cases where VRTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
The Tickeron Profit vs. Risk Rating rating for this company is 13 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. VRTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.848) is normal, around the industry mean (3.596). P/E Ratio (31.605) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (1.939) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (10.449) is also within normal values, averaging (443.347).
VRTX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 13 | |
SMR RATING 1..100 | 41 | |
PRICE GROWTH RATING 1..100 | 43 | |
P/E GROWTH RATING 1..100 | 38 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| FMED | VRTX | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 49% |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 43% |
| MACD ODDS (%) | 2 days ago 88% | 2 days ago 52% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 42% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 36% |
| Advances ODDS (%) | 12 days ago 84% | 13 days ago 64% |
| Declines ODDS (%) | 10 days ago 83% | 2 days ago 43% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 79% |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 64% |
A.I.dvisor indicates that over the last year, FMED has been loosely correlated with BNTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if FMED jumps, then BNTX could also see price increases.
| Ticker / NAME | Correlation To FMED | 1D Price Change % | ||
|---|---|---|---|---|
| FMED | 100% | N/A | ||
| BNTX - FMED | 49% Loosely correlated | -0.52% | ||
| VRTX - FMED | 47% Loosely correlated | -1.08% | ||
| IMVT - FMED | 46% Loosely correlated | -2.31% | ||
| DYN - FMED | 46% Loosely correlated | -3.31% | ||
| KROS - FMED | 45% Loosely correlated | -2.72% | ||
More | ||||